Eisai, Merck Keep Lenvima Patent Alive, Foil Shilpa’s Challenge – Bloomberg Law

Eisai Co. Ltd. and Merck & Co. beat Shilpa Medicare Ltd.’s bid to cancel a key patent for the blockbuster cancer drug Lenvima, a federal judge …